Close

DHX33

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes a member of the DEAD box protein family. The DEAD box proteins are characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. Alternative splicing results in multiple transcript variants.
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0317 Human anti-DHX33 T cell receptor (AA3), pCDTCR1 Human AA3 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0318 Human anti-DHX33 T cell receptor (AC6), pCDTCR1 Human AC6 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0319 Human anti-DHX33 T cell receptor (BD3), pCDTCR1 Human BD3 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0320 Human anti-DHX33 T cell receptor (FE1), pCDTCR1 Human FE1 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0321 Human anti-DHX33 T cell receptor (FF8), pCDTCR1 Human FF8 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0322 Human anti-DHX33 T cell receptor (GD1), pCDTCR1 Human GD1 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0323 Human anti-DHX33 T cell receptor (NC10), pCDTCR1 Human NC10 Human LLAMKVPNV HLA-A2 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.